Sustainable Insight Capital Management LLC grew its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 104.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,900 shares of the company's stock after acquiring an additional 6,600 shares during the quarter. Sustainable Insight Capital Management LLC's holdings in Colgate-Palmolive were worth $1,339,000 at the end of the most recent quarter.
A number of other hedge funds have also recently made changes to their positions in the business. Main Street Research LLC lifted its position in Colgate-Palmolive by 1.5% in the second quarter. Main Street Research LLC now owns 6,939 shares of the company's stock valued at $673,000 after purchasing an additional 100 shares during the last quarter. Advisor OS LLC grew its holdings in Colgate-Palmolive by 4.5% in the 2nd quarter. Advisor OS LLC now owns 2,348 shares of the company's stock worth $228,000 after acquiring an additional 101 shares during the last quarter. BLB&B Advisors LLC increased its position in shares of Colgate-Palmolive by 2.5% in the second quarter. BLB&B Advisors LLC now owns 4,337 shares of the company's stock valued at $421,000 after acquiring an additional 104 shares during the period. ZWJ Investment Counsel Inc. raised its stake in shares of Colgate-Palmolive by 3.1% during the second quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company's stock valued at $349,000 after acquiring an additional 109 shares during the last quarter. Finally, Hexagon Capital Partners LLC boosted its holdings in shares of Colgate-Palmolive by 9.5% during the second quarter. Hexagon Capital Partners LLC now owns 1,274 shares of the company's stock worth $124,000 after purchasing an additional 110 shares during the period. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Stock Performance
NYSE:CL traded up $1.80 during mid-day trading on Friday, reaching $92.57. The company's stock had a trading volume of 4,568,042 shares, compared to its average volume of 4,630,135. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The stock has a market cap of $75.63 billion, a P/E ratio of 26.52, a PEG ratio of 3.22 and a beta of 0.42. The firm's fifty day moving average price is $100.91 and its two-hundred day moving average price is $98.44. Colgate-Palmolive has a 12-month low of $74.67 and a 12-month high of $109.30.
Colgate-Palmolive Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.16%. Colgate-Palmolive's payout ratio is 57.31%.
Insider Transactions at Colgate-Palmolive
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other news, Director Martina Hundmejean sold 2,313 shares of the firm's stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now owns 11,755 shares of the company's stock, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.34% of the company's stock.
Analyst Ratings Changes
CL has been the subject of several research analyst reports. Piper Sandler began coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They issued an "overweight" rating and a $121.00 price objective for the company. Redburn Atlantic upgraded shares of Colgate-Palmolive to a "hold" rating in a report on Thursday, August 1st. Hsbc Global Res downgraded shares of Colgate-Palmolive from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 26th. Wells Fargo & Company cut their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating on the stock in a research report on Monday, October 28th. Finally, Morgan Stanley raised their target price on Colgate-Palmolive from $103.00 to $111.00 and gave the company an "overweight" rating in a research note on Monday, July 29th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive presently has a consensus rating of "Moderate Buy" and an average target price of $105.11.
Check Out Our Latest Stock Analysis on Colgate-Palmolive
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.